Achievement of the ESC recommendations for secondary prevention of cardiovascular risk factors in high-risk patients with type 2 diabetes: A real-world national cohort analysis-Reference-Cited by-同舟云学术

Achievement of the ESC recommendations for secondary prevention of cardiovascular risk factors in high-risk patients with type 2 diabetes: A real-world national cohort analysis

Published:2023-04 Issue: Volume:377 Page:104-111
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Salem Ahmed M.,Harris Daniel,Bray Jonathan J.H.,Obaid Daniel R.,Stephens Jeffrey W.,Halcox Julian

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur. Heart J.,2020

2. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD diseases of the European Society of Cardiology (ESC) and the. 2020;Task,2019

3. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes;Eliaschewitz;N Engl J Med [Internet],2016

4. Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOMETM);Zinman;Cardiovasc Diabetol [Internet],2014

5. ESC/EAS Guidelines for the Management of Dyslipidaemias;Catapano;Eur Heart J,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual cardiovascular risk, use of standard care treatments, and achievement of treatment goals in patients with cardiovascular disease;International Journal of Cardiology Cardiovascular Risk and Prevention;2023-09

2. The tour-de-force for reducing cardiovascular disease risk in diabetic patients;International Journal of Cardiology;2023-07